This is a translation of the table of contents. One article of each issue is translated and freely available.
table of contents

Non-transparent information on research costs of the pharmaceutical industry … absurd calculations of no relevance

All-clear for postmenopaual hormones: how much truth is in it?

Group B meningococcal vaccine TRUMENBA

Cannabis on prescription?

EXSCELL trial with depot exenatide (BYDUREON)

Multiple vertebral fractures following treatment discontinuation of denosumab (PROLIA): EMA refuses to add a warning notice

ACE trial – no cardiovascular benefit of acarbose

Alternative cancer treatments

Atrial fibrillation and coronary stents: erratum

Psoriasis also with tocilizumab (ROACTEMRA)?
free

Oxygen therapy for myocardial infarction and stroke without benefit

Obeticholic acid (OCALIVA): fatal liver damages

arznei-telegramm

Independent drug information – in English

Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

Browse free articles